These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 17880000
1. How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics. Hendriks MM, Smit S, Akkermans WL, Reijmers TH, Eilers PH, Hoefsloot HC, Rubingh CM, de Koster CG, Aerts JM, Smilde AK. Proteomics; 2007 Oct; 7(20):3672-80. PubMed ID: 17880000 [Abstract] [Full Text] [Related]
10. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis]. Cheng L, Zhou L, Tao L, Zhang M, Cui JF, Liu YK. Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2526-30. PubMed ID: 18067823 [Abstract] [Full Text] [Related]
12. Data analysis of assorted serum peptidome profiles. Villanueva J, Philip J, DeNoyer L, Tempst P. Nat Protoc; 2007 Sep 25; 2(3):588-602. PubMed ID: 17406620 [Abstract] [Full Text] [Related]
13. A classification model for the Leiden proteomics competition. Hoefsloot HC, Smit S, Smilde AK. Stat Appl Genet Mol Biol; 2008 Sep 25; 7(2):Article8. PubMed ID: 18312222 [Abstract] [Full Text] [Related]
14. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, Conrad T, Witzigmann H, Weimann A, Schütte C, Hauss J, Büchler M, Thiery J. Clin Cancer Res; 2009 Jun 01; 15(11):3812-9. PubMed ID: 19470732 [Abstract] [Full Text] [Related]
15. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification. Leung SM, Pitts RL. Methods Mol Biol; 2008 Jun 01; 441():57-70. PubMed ID: 18370311 [Abstract] [Full Text] [Related]
16. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Wei YS, Zheng YH, Liang WB, Zhang JZ, Yang ZH, Lv ML, Jia J, Zhang L. Cancer; 2008 Feb 01; 112(3):544-51. PubMed ID: 18085639 [Abstract] [Full Text] [Related]
17. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]. Ma N, Ge CL, Luan FM, Hu CJ, Li YZ, Liu YF. Zhonghua Wai Ke Za Zhi; 2008 Jun 15; 46(12):932-5. PubMed ID: 19035154 [Abstract] [Full Text] [Related]
18. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool. Findeisen P, Peccerella T, Post S, Wenz F, Neumaier M. Rapid Commun Mass Spectrom; 2008 Apr 15; 22(8):1223-9. PubMed ID: 18348224 [Abstract] [Full Text] [Related]
19. Aqueous two-phase partitioning for proteomic monitoring of cell surface biomarkers in human peripheral blood mononuclear cells. Everberg H, Peterson R, Rak S, Tjerneld F, Emanuelsson C. J Proteome Res; 2006 May 15; 5(5):1168-75. PubMed ID: 16674106 [Abstract] [Full Text] [Related]
20. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry. Callesen AK, Christensen Rd, Madsen JS, Vach W, Zapico E, Cold S, Jørgensen PE, Mogensen O, Kruse TA, Jensen ON. Rapid Commun Mass Spectrom; 2008 May 15; 22(3):291-300. PubMed ID: 18181248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]